Cash flow Bide Pharmatech Co., Ltd.

Stocks

688073

CNE100005NV3

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 13/07/2026			5-day change	1st Jan Change
51.49 ^CNY	-2.94%		-5.54%	-15.66%

05-18	Bide Pharmatech's shareholders to unload stake in co	RE
04-29	Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

1bafd91f3f2b57deb8909c01a2c71.PBlV18xMVjzaCrZUQ5W797t7XyRome5_qvpzxdHly-Q.UFARtK44AwnrQd8EdfCPmskpOn0OrqoYwpcd9IuQlIVLRhPuhCZjcog_3Q

Published financial data: BIDE PHARMATECH CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	606M	834M	1.09B	1.1B	1.32B
Other Revenues, Total	169K	31.6K	34.15K	14.1K	4.9K
Total Revenues	606M	834M	1.09B	1.1B	1.32B
Cost of Goods Sold, Total	316M	471M	673M	680M	773M
Gross Profit	290M	363M	418M	422M	550M
Selling General & Admin Expenses, Total	145M	167M	250M	245M	294M
Provision for Bad Debts	3.06M	3.52M	4.33M	1.75M	4.14M
R&D Expenses	32.1M	43.46M	59.72M	55.62M	59.44M
Other Operating Expenses	2.42M	3.64M	5.01M	6.71M	5.27M
Other Operating Expenses, Total	183M	218M	319M	309M	363M
Operating Income	108M	145M	99.3M	113M	188M
Interest Expense, Total	-924K	-2.16M	-2.53M	-3.32M	-5.8M
Interest And Investment Income	3.9M	8.86M	31.74M	23.74M	19.34M
Net Interest Expenses	2.97M	6.7M	29.21M	20.43M	13.54M
Currency Exchange Gains (Loss)	-6.67M	12.55M	5.93M	4.99M	-17.94M
Other Non Operating Income (Expenses)	-1.08M	-2.23M	-2.5M	-4.12M	-2.11M
EBT, Excl. Unusual Items	103M	162M	132M	134M	181M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-464K	-12.63M	3.15M	668K
Gain (Loss) On Sale Of Assets	7.92M	-	439K	1.15M	3.9M
Asset Writedown	-41.2K	-183	-1.48K	-27.48K	-1.11M
Other Unusual Items	3.87M	10.56M	6.25M	9.74M	10.81M
EBT, Incl. Unusual Items	115M	172M	126M	148M	195M
Income Tax Expense	16.99M	25.8M	17.55M	30.59M	43.69M
Earnings From Continuing Operations	97.57M	146M	108M	117M	152M
Net Income to Company	97.57M	146M	108M	117M	152M
Minority Interest	-	-	1.13M	-	-
Net Income - (IS)	97.57M	146M	110M	117M	152M
Net Income to Common Incl Extra Items	97.57M	146M	110M	117M	152M
Net Income to Common Excl. Extra Items	97.57M	146M	110M	117M	152M
Per Share Items
Net EPS - Basic	1.46	1.98	1.21	1.32	1.75
Basic EPS - Continuing Operations	1.46	1.98	1.21	1.32	1.75
Basic Weighted Average Shares Outstanding	66.87M	73.77M	90.56M	88.96M	86.71M
Net EPS - Diluted	1.46	1.98	1.21	1.32	1.73
Diluted EPS - Continuing Operations	1.46	1.98	1.21	1.32	1.73
Diluted Weighted Average Shares Outstanding	66.87M	73.77M	90.56M	88.96M	87.71M
Normalized Basic EPS	0.96	1.37	0.92	0.94	1.31
Normalized Diluted EPS	0.96	1.37	0.92	0.94	1.29
Dividend Per Share	-	1.54	0.9	0.9	1.16
Payout Ratio	0.19	-	91.29	68.03	52.58
Supplemental Items
EBITDA	111M	150M	108M	124M	202M
EBITA	108M	145M	99.3M	113M	188M
EBIT	108M	145M	99.3M	113M	188M
EBITDAR	116M	153M	112M	127M	205M
Total Revenues (As Reported)	-	834M	1.09B	1.1B	1.32B
Effective Tax Rate - (Ratio)	14.83	15.02	13.93	20.67	22.36
Total Current Taxes	16.02M	23.94M	27.9M	27.82M	48.44M
Total Deferred Taxes	965K	1.86M	-10.35M	2.77M	-4.75M
Normalized Net Income	64.25M	101M	83.59M	83.75M	113M
Interest on Long-Term Debt	757K	2.08M	2.49M	2.77M	2.23M
Non-Cash Pension Expense	49.58K	318K	1.43M	2.13M	2.02M
Supplemental Operating Expense Items
Advertising Expense	5.87M	5.65M	7.77M	9.59M	8.18M
Selling and Marketing Expenses	78.39M	92.73M	127M	127M	150M
General and Administrative Expenses	63.99M	71.92M	120M	115M	140M
Research And Development Expense From Footnotes	34.88M	46.07M	63.23M	59.05M	62.72M
Net Rental Expense, Total	4.51M	2.61M	3.51M	3.43M	3.27M
Imputed Operating Lease Interest Expense	1.49M	1.32M	1.45M	1.31M	1.36M
Imputed Operating Lease Depreciation	3.03M	1.29M	2.06M	2.13M	1.91M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	3.66M
Stock-Based Comp., S&M Exp. (Total)	-	-	660K	980K	6.3M
Stock-Based Comp., G&A Exp. (Total)	1.99M	-	2.84M	506K	23.47M
Total Stock-Based Compensation	1.99M	-	3.5M	1.49M	33.42M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	193M	1.51B	1.27B	1.11B	941M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	-	3.97M	123K	75.52M	100M
Total Cash And Short Term Investments	193M	1.51B	1.27B	1.18B	1.04B
Accounts Receivable, Total	125M	177M	237M	227M	261M
Other Receivables	9.89M	11.47M	10.66M	15.39M	15.17M
Total Receivables	135M	189M	248M	243M	276M
Inventory	477M	522M	699M	760M	962M
Prepaid Expenses	37.58K	2.59M	3.63M	4.19M	3.64M
Other Current Assets, Total	13.1M	21.15M	35.89M	20.7M	21.38M
Total Current Assets	818M	2.24B	2.26B	2.21B	2.3B
Gross Property Plant And Equipment	74.12M	107M	150M	235M	216M
Accumulated Depreciation	-14.08M	-31.68M	-52.45M	-67.95M	-63.41M
Net Property Plant And Equipment	60.04M	75.45M	97.32M	167M	153M
Goodwill	-	-	-	-	7.56M
Other Intangibles, Total	443K	212K	601K	3.95M	4.93M
Deferred Tax Assets Long-Term	2.97M	3.88M	18.36M	14.74M	23.91M
Deferred Charges Long-Term	22.13M	16.81M	37.58M	23.74M	19.7M
Other Long-Term Assets, Total	2.84M	18.25M	-	-	2.86M
Total Assets	906M	2.36B	2.42B	2.42B	2.52B
Liabilities
Accounts Payable, Total	206M	167M	180M	216M	202M
Accrued Expenses, Total	18.57M	30.1M	36.26M	31.38M	44.35M
Short-term Borrowings	71.98K	9.61M	231K	30.18M	341K
Current Portion of Long-Term Debt	-	-	-	-	4.55M
Current Portion of Leases	-	-	15.88M	14.06M	14.6M
Current Income Taxes Payable	8.39M	6.22M	6.49M	12.85M	19.22M
Unearned Revenue Current, Total	14.68M	20.52M	29.07M	36.69M	48.31M
Other Current Liabilities	1.78M	15.25M	7.47M	4.28M	7.99M
Total Current Liabilities	250M	249M	275M	346M	342M
Long-Term Debt	-	-	-	-	83.25M
Long-Term Leases	27.71M	31.21M	41.19M	37.95M	38.33M
Deferred Tax Liability Non Current	-	2.77M	8.06M	7.2M	7.94M
Other Non Current Liabilities	-	-	1.27M	-	70.7K
Total Liabilities	277M	283M	325M	391M	471M
Common Stock, Total	48.69M	64.92M	90.88M	90.88M	90.88M
Additional Paid In Capital	483M	1.78B	1.75B	1.76B	1.79B
Retained Earnings	96.51M	242M	252M	290M	364M
Treasury Stock	-	-	-	-99.99M	-200M
Comprehensive Income and Other	431K	-7.25M	-6.96M	-8.6M	-1.63M
Total Common Equity	629M	2.08B	2.09B	2.03B	2.05B
Total Equity	629M	2.08B	2.09B	2.03B	2.05B
Total Liabilities And Equity	906M	2.36B	2.42B	2.42B	2.52B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	68.16M	90.88M	90.88M	88.33M	86.15M
ECS Total Common Shares Outstanding	68.16M	90.88M	90.88M	88.33M	86.15M
Book Value / Share	9.23	22.84	22.99	22.95	23.74
Tangible Book Value	628M	2.08B	2.09B	2.02B	2.03B
Tangible Book Value Per Share	9.22	22.84	22.98	22.91	23.6
Total Debt	27.78M	40.82M	57.3M	82.2M	141M
Net Debt	-166M	-1.47B	-1.22B	-1.1B	-900M
Debt Equivalent Oper. Leases	36.12M	20.89M	28.08M	27.45M	26.19M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	91.05M	104M	-	179M	417M
Inventories - Work In Process, Total	12.38M	15.27M	-	6.58M	2.74M
Inventories - Finished Goods, Total	388M	417M	-	608M	581M
Buildings, Total	16.58M	16.58M	16.58M	85.07M	76.58M
Machinery, Total	21.9M	35.62M	47.23M	45.93M	66.68M
Full Time Employees	534	617	846	738	734
Accumulated Allowance for Doubtful Accounts (Supple)	6.72M	9.69M	-	13.8M	16.48M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	97.57M	146M	110M	117M	152M
Depreciation & Amortization - CF	10.44M	17.61M	26.54M	28.29M	29.87M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	131K	224K
Depreciation & Amortization, Total	10.44M	17.61M	26.54M	28.43M	30.09M
Amortization of Deferred Charges, Total - (CF)	7.71M	8.62M	14.55M	15.25M	9.66M
(Gain) Loss From Sale Of Asset	-7.92M	-	-439K	-856K	-3.9M
(Gain) Loss on Sale of Investments - (CF)	-408K	404K	8.87M	-5.98M	-11.15M
Asset Writedown & Restructuring Costs	41.2K	183	1.48K	27.48K	1.11M
Provision for Credit Losses	-	-	-	-	-
Provision and Write-off of Bad Debts	3.06M	3.52M	4.33M	1.75M	4.14M
Other Operating Activities, Total	11.97M	-5.92M	20.11M	41.23M	54.63M
Change In Accounts Receivable	-58.02M	-74.5M	-45.02M	10.05M	-29.76M
Change In Inventories	-267M	-52.81M	-196M	-96.65M	-232M
Change In Accounts Payable	135M	-14.89M	-1.58M	43.2M	24.94M
Change In Deferred Taxes	965K	1.86M	-10.37M	2.75M	-4.75M
Change in Other Net Operating Assets	1.99M	-	12.32M	1.69M	33.51M
Cash from Operations	-64.88M	29.87M	-57.39M	158M	28.32M
Capital Expenditure	-29.2M	-38.41M	-61.08M	-88.35M	-24.28M
Sale of Property, Plant, and Equipment	15.15M	-	925K	2.2M	10.05M
Cash Acquisitions	-	-	-	-	-7.02M
Investment in Marketable and Equity Securities, Total	43.41M	3.34M	0	-77.92M	-54.78M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	27.23M	-	-
Other Investing Activities, Total	-	-7.54M	4.06M	5.59M	881K
Cash from Investing	29.36M	-42.61M	-28.87M	-158M	-75.15M
Short Term Debt Issued, Total	20.73M	9.61M	-	97.35M	-
Long-Term Debt Issued, Total	-	-	231K	5.6M	254M
Total Debt Issued	20.73M	9.61M	231K	103M	254M
Short Term Debt Repaid, Total	-37.69M	-71.98K	-5M	-68.01M	-194M
Long-Term Debt Repaid, Total	-8.53M	-13.81M	-26.36M	-21.88M	-17.65M
Total Debt Repaid	-46.22M	-13.89M	-31.36M	-89.89M	-212M
Issuance of Common Stock	164M	1.34B	-	-	-
Repurchase of Common Stock	-	-	-	-100M	-100M
Common Dividends Paid	-188K	-	-100M	-79.88M	-79.79M
Common & Preferred Stock Dividends Paid	-188K	-	-100M	-79.88M	-79.79M
Other Financing Activities, Total	-773K	-20.6M	-7.15M	0	0
Cash from Financing	137M	1.31B	-138M	-167M	-138M
Foreign Exchange Rate Adjustments	-301K	4.73M	-5.83M	-1.44M	-8.77M
Net Change in Cash	102M	1.3B	-230M	-168M	-194M
Supplemental Items
Cash Interest Paid	-	83.58K	-	-	-
Cash Income Tax Paid (Refund)	12.74M	25.48M	2.5M	19.77M	14.35M
Levered Free Cash Flow	-121M	-43.34M	-189M	26.94M	-52.11M
Unlevered Free Cash Flow	-120M	-41.99M	-187M	29.01M	-48.48M
Change In Net Working Capital	178M	120M	233M	-1.75M	215M
Net Debt Issued / Repaid	-25.49M	-4.28M	-31.12M	13.06M	41.76M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	9.51	5.54	2.6	2.92	4.75
Return on Total Capital	12.96	6.52	2.91	3.31	5.46
Return On Equity %	19.65	10.79	5.21	5.7	7.45
Return on Common Equity	19.65	10.79	5.26	5.7	7.45
Margin Analysis
Gross Profit Margin %	47.89	43.48	38.33	38.26	41.58
SG&A Margin	23.95	20.06	22.91	22.22	22.21
EBITDA Margin %	18.36	18.04	9.93	11.21	15.25
EBITA Margin %	17.75	17.35	9.09	10.24	14.19
EBIT Margin %	17.75	17.35	9.09	10.23	14.18
Income From Continuing Operations Margin %	16.1	17.51	9.93	10.66	11.46
Net Income Margin %	16.1	17.51	10.04	10.66	11.46
Net Avail. For Common Margin %	16.1	17.51	10.04	10.66	11.46
Normalized Net Income Margin	10.6	12.12	7.66	7.6	8.55
Levered Free Cash Flow Margin	-19.88	-5.2	-17.3	2.44	-3.94
Unlevered Free Cash Flow Margin	-19.79	-5.04	-17.16	2.63	-3.66
Asset Turnover
Asset Turnover	0.86	0.51	0.46	0.46	0.54
Fixed Assets Turnover	16.09	12.31	12.64	8.34	8.28
Receivables Turnover (Average Receivables)	5.78	5.52	5.27	4.74	5.42
Inventory Turnover (Average Inventory)	0.91	0.94	1.1	0.93	0.9
Short Term Liquidity
Current Ratio	3.28	9.01	8.22	6.39	6.74
Quick Ratio	1.31	6.82	5.54	4.12	3.86
Operating Cash Flow to Current Liabilities	-0.26	0.12	-0.21	0.46	0.08
Days Sales Outstanding (Average Receivables)	63.12	66.11	69.32	77.17	67.35
Days Outstanding Inventory (Average Inventory)	401.75	386.62	330.99	392.62	406.43
Average Days Payable Outstanding	92.03	131.92	74.41	97.75	78.38
Cash Conversion Cycle (Average Days)	372.84	320.8	325.91	372.04	395.4
Long Term Solvency
Total Debt/Equity	4.42	1.97	2.74	4.06	6.9
Total Debt / Total Capital	4.23	1.93	2.67	3.9	6.45
LT Debt/Equity	4.41	1.5	1.97	1.87	5.94
Long-Term Debt / Total Capital	4.22	1.47	1.92	1.8	5.56
Total Liabilities / Total Assets	30.6	12	13.48	16.17	18.73
EBIT / Interest Expense	116.42	66.86	39.24	33.99	32.35
EBITDA / Interest Expense	127.71	75	49.73	42.56	37.54
(EBITDA - Capex) / Interest Expense	96.11	57.24	25.59	15.92	33.35
Total Debt / EBITDA	0.24	0.25	0.46	0.58	0.65
Net Debt / EBITDA	-1.4	-9.06	-9.67	-7.78	-4.13
Total Debt / (EBITDA - Capex)	0.31	0.33	0.88	1.56	0.73
Net Debt / (EBITDA - Capex)	-1.87	-11.86	-18.79	-20.81	-4.65
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	54.86	37.55	30.94	0.93	20.13
Gross Profit, 1 Yr. Growth %	42.22	24.87	15.43	0.76	30.55
EBITDA, 1 Yr. Growth %	41.59	34.93	-27.76	13.53	62.64
EBITA, 1 Yr. Growth %	41.32	34.17	-31.21	13.19	65.72
EBIT, 1 Yr. Growth %	41.36	34.46	-31.21	13.51	66.1
Earnings From Cont. Operations, 1 Yr. Growth %	65.37	49.6	-25.71	8.28	29.22
Net Income, 1 Yr. Growth %	65.37	49.6	-24.94	7.17	29.22
Normalized Net Income, 1 Yr. Growth %	54.92	57.26	-17.11	0.19	34.91
Diluted EPS Before Extra, 1 Yr. Growth %	53.38	35.79	-38.89	9.09	31.06
Accounts Receivable, 1 Yr. Growth %	46.78	42.26	33.82	-4.21	14.86
Inventory, 1 Yr. Growth %	117.76	9.51	34.03	8.69	26.54
Net Property, Plant and Equip., 1 Yr. Growth %	291.73	25.65	28.99	71.47	-8.31
Total Assets, 1 Yr. Growth %	78.49	160.36	2.37	0.12	4.08
Tangible Book Value, 1 Yr. Growth %	72.84	230.34	0.63	-3.15	0.48
Common Equity, 1 Yr. Growth %	72.64	230.15	0.64	-2.99	0.9
Cash From Operations, 1 Yr. Growth %	-1.88K	-146.04	-292.12	-375.87	-82.11
Capital Expenditures, 1 Yr. Growth %	-22.6	31.53	59.01	44.64	-72.51
Levered Free Cash Flow, 1 Yr. Growth %	45.73	-64.05	331.55	-114.26	-290.73
Unlevered Free Cash Flow, 1 Yr. Growth %	47.11	-65	341.57	-115.49	-264.94
Dividend Per Share, 1 Yr. Growth %	-	-	-18.18	0	28.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	56.16	45.95	34.2	14.96	10.11
Gross Profit, 2 Yr. CAGR %	44.72	33.26	20.06	7.85	14.69
EBITDA, 2 Yr. CAGR %	320.63	38.37	-1.38	-9.28	36.18
EBITA, 2 Yr. CAGR %	397.85	37.85	-4.03	-11.58	37.29
EBIT, 2 Yr. CAGR %	397.85	37.86	-3.93	-11.63	37.48
Earnings From Cont. Operations, 2 Yr. CAGR %	840.77	57.29	5.42	-10.31	18.29
Net Income, 2 Yr. CAGR %	840.77	57.29	5.97	-10.31	17.68
Normalized Net Income, 2 Yr. CAGR %	504.45	56.09	14.06	-8.87	16.39
Diluted EPS Before Extra, 2 Yr. CAGR %	236.61	44.32	-8.87	-18.35	19.57
Accounts Receivable, 2 Yr. CAGR %	54.3	44.5	37.98	13.22	4.89
Inventory, 2 Yr. CAGR %	91.07	54.42	21.15	20.7	17.28
Net Property, Plant and Equip., 2 Yr. CAGR %	120.31	121.86	27.31	48.72	25.39
Total Assets, 2 Yr. CAGR %	84.73	115.57	63.25	1.24	2.09
Tangible Book Value, 2 Yr. CAGR %	114.8	138.95	82.32	-1.28	-1.35
Common Equity, 2 Yr. CAGR %	114.88	138.74	82.28	-1.19	-1.06
Cash From Operations, 2 Yr. CAGR %	365.95	186.27	-5.95	130.21	-29.75
Capital Expenditures, 2 Yr. CAGR %	152.19	0.9	44.62	51.66	-36.95
Levered Free Cash Flow, 2 Yr. CAGR %	44.5	-27.61	25.19	-21.55	-47.48
Unlevered Free Cash Flow, 2 Yr. CAGR %	45.89	-28.24	24.96	-17.3	-49.13
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-9.55	13.53
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	54.94	49.69	40.76	22.04	16.66
Gross Profit, 3 Yr. CAGR %	47.01	37.78	27.03	13.25	14.94
EBITDA, 3 Yr. CAGR %	111.84	188.14	11.34	3.49	10.37
EBITA, 3 Yr. CAGR %	99.52	221.81	9.26	1.53	9.19
EBIT, 3 Yr. CAGR %	99.52	221.81	9.27	1.56	9.14
Earnings From Cont. Operations, 3 Yr. CAGR %	73.04	409.69	22.49	6.37	1.3
Net Income, 3 Yr. CAGR %	73.04	409.69	22.92	6.37	1.3
Normalized Net Income, 3 Yr. CAGR %	83.22	285.88	26.32	9.24	3.94
Diluted EPS Before Extra, 3 Yr. CAGR %	-20.85	148.72	8.4	-3.24	-4.4
Accounts Receivable, 3 Yr. CAGR %	57.49	50.18	40.85	22.17	13.76
Inventory, 3 Yr. CAGR %	85	58.72	47.3	16.85	22.61
Net Property, Plant and Equip., 3 Yr. CAGR %	147.73	82.7	85.17	40.6	26.58
Total Assets, 3 Yr. CAGR %	77.43	107.12	68.18	38.7	2.18
Tangible Book Value, 3 Yr. CAGR %	224.71	147.94	79.11	47.66	-0.7
Common Equity, 3 Yr. CAGR %	224.78	147.95	79.01	47.72	-0.5
Cash From Operations, 3 Yr. CAGR %	89.85	115.41	150.63	34.63	-1.76
Capital Expenditures, 3 Yr. CAGR %	61.2	103	17.42	44.63	-14.17
Levered Free Cash Flow, 3 Yr. CAGR %	-	-9.12	31.69	-39.31	5.98
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-9.35	31.95	-37.7	4.55
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	1.79
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	46.29	34.69	27.59
Gross Profit, 5 Yr. CAGR %	-	-	35.57	24.92	21.94
EBITDA, 5 Yr. CAGR %	-	-	56.09	81.41	20.77
EBITA, 5 Yr. CAGR %	-	-	48.95	91.86	19.81
EBIT, 5 Yr. CAGR %	-	-	48.95	91.81	19.78
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	41.93	154.38	20.79
Net Income, 5 Yr. CAGR %	-	-	42.22	154.38	20.79
Normalized Net Income, 5 Yr. CAGR %	-	-	51.58	116.55	22.25
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-16.26	59.32	12.74
Accounts Receivable, 5 Yr. CAGR %	-	-	49.37	34.13	25.19
Inventory, 5 Yr. CAGR %	-	-	56.18	42.25	34.46
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	89.82	68.27	58.44
Total Assets, 5 Yr. CAGR %	-	-	71.62	55.55	37.74
Tangible Book Value, 5 Yr. CAGR %	-	-	157.77	71.54	41.09
Common Equity, 5 Yr. CAGR %	-	-	157.78	71.61	41.21
Cash From Operations, 5 Yr. CAGR %	-	-	43.34	121.21	50.69
Capital Expenditures, 5 Yr. CAGR %	-	-	54.35	80.65	-8.43
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-14.14	-8.83
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-12.44	-9.88